GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » EV-to-EBITDA

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) EV-to-EBITDA : 49.57 (As of Jun. 06, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Qianjiang Yongan Pharmaceutical Co's enterprise value is ¥1,250.4 Mil. Qianjiang Yongan Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥25.2 Mil. Therefore, Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA for today is 49.57.

The historical rank and industry rank for Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA or its related term are showing as below:

SZSE:002365' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.45   Med: 29.44   Max: 4158.21
Current: 49.57

During the past 13 years, the highest EV-to-EBITDA of Qianjiang Yongan Pharmaceutical Co was 4158.21. The lowest was 11.45. And the median was 29.44.

SZSE:002365's EV-to-EBITDA is ranked worse than
90.18% of 713 companies
in the Drug Manufacturers industry
Industry Median: 14.07 vs SZSE:002365: 49.57

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), Qianjiang Yongan Pharmaceutical Co's stock price is ¥7.00. Qianjiang Yongan Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.004. Therefore, Qianjiang Yongan Pharmaceutical Co's PE Ratio for today is 1,750.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Qianjiang Yongan Pharmaceutical Co EV-to-EBITDA Historical Data

The historical data trend for Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianjiang Yongan Pharmaceutical Co EV-to-EBITDA Chart

Qianjiang Yongan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.68 8.97 10.84 8.61 14.12

Qianjiang Yongan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.63 22.48 46.84 14.12 53.29

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA falls into.



Qianjiang Yongan Pharmaceutical Co EV-to-EBITDA Calculation

Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1250.394/25.223
=49.57

Qianjiang Yongan Pharmaceutical Co's current Enterprise Value is ¥1,250.4 Mil.
Qianjiang Yongan Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥25.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianjiang Yongan Pharmaceutical Co  (SZSE:002365) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Qianjiang Yongan Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.00/0.004
=1,750.00

Qianjiang Yongan Pharmaceutical Co's share price for today is ¥7.00.
Qianjiang Yongan Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Qianjiang Yongan Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100
Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.
Executives
Mei Song Lin Executives
Wang Zhi Hua Executives
Hong Ren Gui Executives
Wu Yu Xi Directors, executives
Dai Xiang Zhen Executives
Wu Xiao Bo Directors, executives
Luo Bai Neng Executives
Ding Hong Li Directors, executives
Fang Xi Quan Executives
Li Shao Bo Executives
Deng Yong Hong Securities Affairs Representative
Dong Shi Hao Executives
Wu Guo Sen Supervisors
Lv Xin Wu Executives
Chen Yong Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines